Literature DB >> 18458989

Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect?

Eishi Miyazaki1, Masaru Ando, Tetsujiro Fukami, Shin-Ichi Nureki, Yoshinobu Eishi, Toshihide Kumamoto.   

Abstract

A 47-year-old female was diagnosed to have pulmonary, ocular, and nodular-type muscular sarcoidosis. Seven years later, nodules developed in all limb muscles. She received minocycline 200 mg daily, which resulted in an obvious reduction of the muscular sarcoidosis with a significant decrease in the serum angiotensin-converting enzyme level. Nine months later, the minocycline was discontinued, thus resulting in a rapid recurrence of the disease. The immediate readministration of minocycline again resulted in a prompt improvement. We detected Propionibacterium acnes within the granulomas in the affected muscle by an immunohistochemistry. More interestingly, we found a decrease in the circulating levels of interleukin-12 p40 and interferon-inducible protein-10 during the minocycline therapy. The minocycline therapy may be effective for sarcoidosis and the fact that the disease rapidly relapsed after discontinuation of the minocycline administration suggests that the mechanism of action in this case may be immunomodulating but not antimicrobial effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458989     DOI: 10.1007/s10067-008-0903-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  Minocycline for the treatment of ocular and ocular adnexal sarcoidosis.

Authors:  D J John Park; John J Woog; Jose S Pulido; J Douglas Cameron
Journal:  Arch Ophthalmol       Date:  2007-05

2.  Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis.

Authors:  I Ishige; Y Usui; T Takemura; Y Eishi
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

3.  The use of tetracyclines for the treatment of sarcoidosis.

Authors:  H Bachelez; P Senet; J Cadranel; A Kaoukhov; L Dubertret
Journal:  Arch Dermatol       Date:  2001-01

4.  Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues.

Authors:  Y H Thong; A Ferrante
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

5.  Circulating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical markers.

Authors:  Masahiro Hata; Katsunori Sugisaki; Eishi Miyazaki; Toshihide Kumamoto; Tomiyasu Tsuda
Journal:  Intern Med       Date:  2007-09-03       Impact factor: 1.271

6.  Involvement of the IP-10 chemokine in sarcoid granulomatous reactions.

Authors:  C Agostini; M Cassatella; R Zambello; L Trentin; S Gasperini; A Perin; F Piazza; M Siviero; M Facco; M Dziejman; M Chilosi; S Qin; A D Luster; G Semenzato
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

7.  Differential expression of chemokines and chemokine receptors during microglial activation and inhibition.

Authors:  Sergey G Kremlev; Rebecca L Roberts; Charles Palmer
Journal:  J Neuroimmunol       Date:  2004-04       Impact factor: 3.478

8.  Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C.

Authors:  G F Webster; S M Toso; L Hegemann
Journal:  Arch Dermatol       Date:  1994-06
  8 in total
  8 in total

Review 1.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

2.  Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium.

Authors:  Mariko Negi; Tamiko Takemura; Josune Guzman; Keisuke Uchida; Asuka Furukawa; Yoshimi Suzuki; Tadatsune Iida; Ikuo Ishige; Junko Minami; Tetsuo Yamada; Hiroshi Kawachi; Ulrich Costabel; Yoshinobu Eishi
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

Review 3.  Is there any association between Sarcoidosis and infectious agents?: a systematic review and meta-analysis.

Authors:  Tiago Esteves; Gloria Aparicio; Vicente Garcia-Patos
Journal:  BMC Pulm Med       Date:  2016-11-28       Impact factor: 3.317

Review 4.  The Role of Cutibacterium acnes in Sarcoidosis: From Antigen to Treatable Trait?

Authors:  Raisa Kraaijvanger; Marcel Veltkamp
Journal:  Microorganisms       Date:  2022-08-15

5.  Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes.

Authors:  Yoshinobu Eishi
Journal:  Biomed Res Int       Date:  2013-06-16       Impact factor: 3.411

Review 6.  The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis.

Authors:  Lindsay J Celada; Charlene Hawkins; Wonder P Drake
Journal:  Clin Chest Med       Date:  2015-09-19       Impact factor: 2.878

7.  Successful treatment in a case of Propionibacterium acnes-associated sarcoidosis with clarithromycin administration: a case report.

Authors:  Nobuo Takemori; Masaya Nakamura; Masaru Kojima; Yoshinobu Eishi
Journal:  J Med Case Rep       Date:  2014-01-15

Review 8.  Environmental Risk Factors for Sarcoidosis.

Authors:  Marc A Judson
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.